Contractor
REVAGENIX INC
SAN MATEO, CA
- UEI
- D98QFZUPFXJ9
- Parent UEI
- D98QFZUPFXJ9
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$55,112,1881
Awards
2
Agencies served
1
Active from Mar 23, 2026 to Jul 10, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75N93020C00018 TO SELECT A NOVEL SMALL MOLECULE ANTIBIOTIC FOR CLINICAL DEVELOPMENT AND ADVANCE IT THROUGH IND FILING AND PHASE 1 CLINICAL STUDIES. | Department of Health and Human Services | CA | Jul 10, 2026 | $26,944,787 |
| 75N93022C00061 A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. | Department of Health and Human Services | CA | Mar 23, 2026 | $28,167,401 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier D98QFZUPFXJ9, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.